ELISHA CARTER: Open Payments
NPI 1992040778 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 30 payments from 9 companies in 2025. Trend: 2023 $1,139 · 2024 $1,012 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $185 |
| ABBVIE INC. | 4 | $78 |
| Collegium Pharmaceutical, Inc. | 4 | $75 |
| PFIZER INC. | 3 | $59 |
| BIOTRONIK NRO, Inc. | 3 | $51 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $31 |
| Averitas Pharma Inc. | 1 | $25 |
| SCILEX PHARMACEUTICALS INC. | 1 | $20 |
| Valinor Pharma, LLC | 1 | $14 |
Products named: RELISTOR, Belbuca, NURTEC ODT, Prospera, QULIPTA, UBRELVY, JOURNAVX, QUTENZA.
Industry payments across MD — which companies pay providers there.
